← Back to Search
Genotoxicity Assessment Of Magnetic Iron Oxide Nanoparticles With Different Particle Sizes And Surface Coatings.
Y. Liu, Qiyue Xia, Ying Liu, S. Zhang, F. Cheng, Zhihui Zhong, L. Wang, H. Li, K. Xiao
Published 2014 · Materials Science, Medicine
Download PDFAnalyze on Scholarcy
Magnetic iron oxide nanoparticles (IONPs) have been widely used for various biomedical applications such as magnetic resonance imaging and drug delivery. However, their potential toxic effects, including genotoxicity, need to be thoroughly understood. In the present study, the genotoxicity of IONPs with different particle sizes (10, 30 nm) and surface coatings (PEG, PEI) were assessed using three standard genotoxicity assays, the Salmonella typhimurium reverse mutation assay (Ames test), the in vitro mammalian chromosome aberration test, and the in vivo micronucleus assay. In the Ames test, SMG-10 (PEG coating, 10 nm) showed a positive mutagenic response in all the five test bacterial strains with and without metabolic activation, whereas SEI-10 (PEI coating, 10 nm) showed no mutagenesis in all tester strains regardless of metabolic activation. SMG-30 (PEG coating, 30 nm) was not mutagenic in the absence of metabolic activation, and became mutagenic in the presence of metabolic activation. In the chromosomal aberration test, no increase in the incidence of chromosomal aberrations was observed for all three IONPs. In the in vivo micronucleus test, there was no evidence of increased micronuclei frequencies for all three IONPs, indicating that they were not clastogenic in vivo. Taken together, our results demonstrated that IONPs with PEG coating exhibited mutagenic activity without chromosomal and clastogenic abnormalities, and smaller IONPs (SMG-10) had stronger mutagenic potential than larger ones (SMG-30); whereas, IONPs with SEI coating (SEI-10) were not genotoxic in all three standard genotoxicity assays. This suggests that the mutagenicity of IONPs depends on their particle size and surface coating.
This paper references
Potential toxic effects of iron oxide nanoparticles in in vivo and in vitro experiments
B. Szalay (2012)
Biomedical applications and potential health risks of nanomaterials: molecular mechanisms.
S. Lanone (2006)
Comprar Nanotoxicity: From In Vivo and In Vitro Models to Health Risks | Novartis Foundation | 9780470741375 | Wiley
S. Sahu (2009)
Gene Expression Profiles for Genotoxic Effects of Silica-Free and Silica-Coated Cobalt Ferrite Nanoparticles
D. Hwang (2012)
Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
F. Alexis (2008)
Translocation and fate of multi-walled carbon nanotubes in vivo
X. Deng (2007)
Genotoxicity of Metal Nanoparticles: Focus on In Vivo Studies
K. Klien (2012)
Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles.
W. Cho (2009)
Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers.
R. Singh (2006)
Nanoparticles--a historical perspective.
J. Kreuter (2007)
Exposure to nanoparticles is related to pleural effusion, pulmonary fibrosis and granuloma
Y. Song (2009)
Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection.
B. Ames (1973)
Role of surface charge and oxidative stress in cytotoxicity of organic monolayer-coated silicon nanoparticles towards macrophage NR8383 cells
Sourav Bhattacharjee (2010)
Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice.
Bénédicte Trouiller (2009)
Nanoparticle Surface Charges Alter Blood–Brain Barrier Integrity and Permeability
P. Lockman (2004)
Evaluation of genotoxicity of amine-terminated water-dispersible FePt nanoparticles in the Ames test and in vitro chromosomal aberration test.
S. Maenosono (2009)
Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.
B. Ames (1975)
Cellular Uptake and Trafficking of a Prototypical Magnetic Iron Oxide Label In Vitro
E. Schulze (1995)
Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length
C. Lherm (1992)
Controlled PEGylation of Monodisperse Fe3O4 Nanoparticles for Reduced Non‐Specific Uptake by Macrophage Cells
J. Xie (2007)
Low doses of pristine and oxidized single-wall carbon nanotubes affect mammalian embryonic development.
A. Pietroiusti (2011)
Type-II quantum dots: CdTe/CdSe(core/shell) and CdSe/ZnTe(core/shell) heterostructures.
S. Kim (2003)
Sheddable Coatings for Long-Circulating Nanoparticles
B. Romberg (2007)
NanoGenotoxicology: the DNA damaging potential of engineered nanomaterials.
N. Singh (2009)
Alternatives to Aroclor 1254-induced S9 in in vitro genotoxicity assays.
B. Elliott (1992)
Revised methods for the Salmonella mutagenicity test.
D. Maron (1983)
Toxicity of nanomaterials.
S. Sharifi (2012)
Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation.
K. W. Powers (2006)
The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.
K. Xiao (2011)
Effects of nanomaterial physicochemical properties on in vivo toxicity.
Kristin L Aillon (2009)
Principle and applications of terahertz molecular imaging.
J. Son (2013)
Toxicity of gold nanoparticles functionalized with cationic and anionic side chains.
Catherine M Goodman (2004)
Genotoxicity evaluation of titanium dioxide nanoparticles using the Ames test and Comet assay
Robert S. Woodruff (2012)
Developmental toxicity of low generation PAMAM dendrimers in zebrafish.
T. K. Heiden (2007)
Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge
J. Geys (2008)
Cationic carriers of genetic material and cell death: a mitochondrial tale.
A. C. Hunter (2010)
Inhibition of Human Cytochrome P450 Enzymes by Metallic Nanoparticles: A Preliminary to Nanogenomics
A. Sereemaspun (2008)
In vitro toxicological assessment of iron oxide, aluminium oxide and copper nanoparticles in prokaryotic and eukaryotic cell types
Rakhshinda Sadiq (2015)
Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro.
C. Berry (2003)
Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis.
J. Rejman (2004)
Cytotoxicity, oxidative stress, and genotoxicity in human hepatocyte and embryonic kidney cells exposed to ZnO nanoparticles
Rongfa Guan (2012)
Silver nanoparticles induced heat shock protein 70, oxidative stress and apoptosis in Drosophila melanogaster.
M. Ahamed (2010)
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer.
K. Xiao (2009)
Physicochemical Properties and Cellular Toxicity of Nanocrystal Quantum Dots Depend on Their Surface Modification
A. Hoshino (2004)
Current Studies into the Genotoxic Effects of Nanomaterials
Cheng-Teng Ng (2010)
Cellular uptake and mutagenic potential of metal oxide nanoparticles in bacterial cells.
A. Kumar (2011)
Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress
S. Naqvi (2010)
Characterization of the size, shape, and state of dispersion of nanoparticles for toxicological studies
K. Powers (2007)
DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells.
M. Ahamed (2008)
Toxic Potential of Materials at the Nanolevel
A. Nel (2006)
Evaluation of in vitro mutagenicity and genotoxicity of magnetite nanoparticles.
I. Gomaa (2013)
Mutagenicity of water-soluble ZnO nanoparticles in Ames test.
R. Yoshida (2009)
Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
Y. Hu (2007)
Dendrimer-platinate: a novel approach to cancer chemotherapy.
N. Malik (1999)
Enhanced in vitro and in vivo toxicity of poly-dispersed acid-functionalized single-wall carbon nanotubes
R. K. Saxena (2007)
This paper is referenced by
MUTAGENIC ACTIVITY OF NANOMATERIALS IN THE AMES TEST. LITERATURE REVIEW
L. V. Akhaltseva (2019)
Multivariate modeling of engineered nanomaterial features associated with developmental toxicity.
Kimberly To (2019)
Uptake, distribution, clearance, and toxicity of iron oxide nanoparticles with different sizes and coatings
Qiyi Feng (2018)
Studies on Tissue Plasminogen Activator: Efficiency of Thrombolysis in the Presence of Iodinated Contrast Media and Development of a Novel Targeted t-PA Delivery System
Vörös Eszter (2018)
Toxicological assessment of silica-coated iron oxide nanoparticles in human astrocytes.
Natalia Fernández-Bertólez (2018)
Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods
R. Elespuru (2018)
Mechanisms of antibiotic resistance in bacteria mediated by silver nanoparticles
Chitrada Kaweeteerawat (2017)
Cellular and Molecular Toxicity of Iron Oxide Nanoparticles.
B. Laffon (2018)
Boron Compounds Counteracts Oxidative Stress Mediated Genotoxicity Induced by Fe3O4 Nanoparticles In Vitro
H. Türkez (2016)
Iron oxide nanoparticles decrease nuclear fractal dimension of buccal epithelial cells in a time‐dependent manner
D. Nikolovski (2017)
Surface-modified magnetite nanoparticles act as aneugen-like spindle poison.
Barbora Buliaková (2017)
Environmental implications and applications of engineered nanoscale magnetite and its hybrid nanocomposites: A review of recent literature.
C. Su (2017)
In Vitro/In Vivo Toxicity Evaluation and Quantification of Iron Oxide Nanoparticles
U. Patil (2015)
Immunological effects of iron oxide nanoparticles and iron-based complex drug formulations: Therapeutic benefits, toxicity, mechanistic insights, and translational considerations.
Ankit Shah (2018)
Progress in Genotoxicity Evaluation of Engineered Nanomaterials
X. Guo (2015)
Genotoxic and mutagenic assessment of iron oxide (maghemite-γ-Fe2O3) nanoparticle in the guppy Poecilia reticulata.
G. Qualhato (2017)
Evaluation of cytotoxicity and genotoxicity induced by oleic acid‐coated iron oxide nanoparticles in human astrocytes
Natalia Fernández-Bertólez (2019)
Current highlights about the safety of inorganic nanomaterials in healthcare.
L. Perioli (2018)
Toxicity and Transcriptome Sequencing (RNA-seq) Analyses of Adult Zebrafish in Response to Exposure to Stabilized FeS and Fe3O4 Nanoparticles
M. Zheng (2017)
Dye-doped biodegradable nanoparticle SiO2 coating on zinc- and iron-oxide nanoparticles to improve biocompatibility and for in vivo imaging studies.
Elena Navarro-Palomares (2020)
Preclinical Evaluation and Clinical Translation of Magnetite-Based Nanomedicines
Julia V. Nuzhina (2019)
Magnetic Nanoparticle Nanoformulations for Alternative Therapy of Cancer by Magnetic/Superparamagnetic Hyperthermia
C. Caizer (2020)
Preparation and characterization of cetyltrimethylammonium bromide (CTAB)-stabilized Fe3O4 nanoparticles for electrochemistry detection of citric acid
J. A. R. Guivar (2015)
Effects of starch-coating of magnetite nanoparticles on cellular uptake, toxicity and gene expression profiles in adult zebrafish.
Min Zheng (2018)
Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents.
R. Chen (2015)
Evaluating Anticancer Activity of Plant-Mediated Synthesized Iron Oxide Nanoparticles Using Punica Granatum Fruit Peel Extract
Mostafa Yusefi (2020)
Methods and Techniques in Molecular Toxicology of Nanomaterials
Y. Wang (2016)
Nanotoxicology: A Review
C. Walters (2016)
Nanomaterials and genotoxicity – a literature review, Report 13/16
Nanomaterials and Cell Interactions: A Review
T. Jackson (2017)
Are iron oxide nanoparticles safe? Current knowledge and future perspectives.
Vanessa Valdiglesias (2016)